van Kleef R C, van Vliet R C J A, van Rooijen E M
Erasmus University Rotterdam, Institute of Health Policy and Management, The Netherlands.
Erasmus University Rotterdam, Institute of Health Policy and Management, The Netherlands.
Health Policy. 2014 Mar;115(1):52-9. doi: 10.1016/j.healthpol.2013.07.005. Epub 2013 Jul 31.
The Dutch basic health-insurance scheme for curative care includes a risk equalization model (RE-model) to compensate competing health insurers for the predictable high costs of people in poor health. Since 2004, this RE-model includes the so-called Diagnoses-based Cost Groups (DCGs) as a risk adjuster. Until 2013, these DCGs have been mainly based on diagnoses from inpatient hospital treatment.
This paper examines (1) to what extent the Dutch RE-model can be improved by extending the inpatient DCGs with diagnoses from outpatient hospital treatment and (2) how to treat outpatient diagnoses relative to their corresponding inpatient diagnoses.
Based on individual-level administrative costs we estimate the Dutch RE-model with three different DCG modalities. Using individual-level survey information from a prior year we examine the outcomes of these modalities for different groups of people in poor health.
We find that extending DCGs with outpatient diagnoses has hardly any effect on the R-squared of the RE-model, but reduces the undercompensation for people with a chronic condition by about 8%. With respect to incentives, it may be preferable to make no distinction between corresponding inpatient and outpatient diagnoses in the DCG-classification, although this will be at the expense of the predictive accuracy of the RE-model.
荷兰基本医疗保健保险计划中的治疗护理包含一种风险均等化模型(RE模型),用于补偿相互竞争的健康保险公司因健康状况不佳者可预测的高成本。自2004年以来,该RE模型将所谓的基于诊断的成本组(DCG)作为风险调整因素。直到2013年,这些DCG主要基于住院医院治疗的诊断。
本文研究(1)通过将门诊医院治疗的诊断纳入住院DCG来改进荷兰RE模型的程度,以及(2)相对于相应的住院诊断,如何处理门诊诊断。
基于个体层面的管理成本,我们用三种不同的DCG模式估计荷兰RE模型。利用上一年的个体层面调查信息,我们研究了这些模式对不同健康状况不佳人群的结果。
我们发现,将门诊诊断纳入DCG对RE模型的决定系数几乎没有影响,但将慢性病患者的补偿不足减少了约8%。关于激励措施,在DCG分类中对相应的住院和门诊诊断不做区分可能更可取,尽管这将以牺牲RE模型的预测准确性为代价。